| Sarcopenia is a clinical syndrome characterized by decreased skeletal muscle mass and strength during aging, accompanied by disability, reduced quality of life, and even death. Sarcopenia is widespread in the elderly and seriously affects the quality of life. It is an important public health issue in current society. At present, the international diagnosis and screening methods for sarcopenia have not been unified. A number of organizations have developed their own consensus on sarcopenia, each of which proposes a diagnostic cut-off point for sarcopenia, and uses grip strength and gait speed to evaluate the muscle condition of the elderly in clinical practice. Menopause is an age-related physiological condition associated with naturally declining estrogen levels, which can lead to a decrease in muscle mass and strength and an increase in the prevalence of sarcopenia. Changes in muscle mass, function, muscle composition in postmenopausal women are associated with decreased estrogen levels and are also affected by a variety of factors, such as nutrition, exercise, environment, and genetics. Currently, there is no clear treatment for sarcopenia. However, the existing evidence suggests that dietary nutrition, impedance exercise, and sex hormone replacement therapy play an important role in improving the quality and strength of muscles in postmenopausal women. The relationship between menopause and sarcopenia is still in the exploratory stage, and there are still many problems worthy of further study. This article reviews the diagnosis of sarcopenia and the relationship between postmenopausal hormone changes and age-related sarcopenia. |